|
HUE041576T2
(hu)
|
2011-09-14 |
2019-05-28 |
Samumed Llc |
Indazol-3-karboxamid-származékok és alkalmazásuk Wnt/b-katenin szignalizáló útvonal inhibitorokként
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
WO2014139882A1
(en)
|
2013-03-14 |
2014-09-18 |
Galapagos Nv |
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
|
CN105339370B
(zh)
|
2013-06-19 |
2017-09-15 |
加拉帕戈斯股份有限公司 |
用于治疗炎症性疾病的化合物和及其药物组合物
|
|
US9943677B2
(en)
|
2013-10-15 |
2018-04-17 |
Radux Devices, LLC |
Securing a medical device to a valve instrument
|
|
PL3197277T3
(pl)
|
2014-08-29 |
2022-04-04 |
Chdi Foundation, Inc. |
Sondy do obrazowania molekularnego białka huntingtyny
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
GB201501870D0
(en)
|
2015-02-04 |
2015-03-18 |
Cancer Rec Tech Ltd |
Autotaxin inhibitors
|
|
GB201502020D0
(en)
|
2015-02-06 |
2015-03-25 |
Cancer Rec Tech Ltd |
Autotaxin inhibitory compounds
|
|
US10118904B2
(en)
|
2015-06-05 |
2018-11-06 |
Vertex Pharmaceuticals Incorporated |
Triazoles for the treatment of Demyelinating Diseases
|
|
JP6871919B2
(ja)
|
2015-06-16 |
2021-05-19 |
ナノファギックス エルエルシー |
薬物送達及びイメージング化学コンジュゲート、製剤及びその使用方法
|
|
WO2017023989A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017023980A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
WO2017023987A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10350199B2
(en)
|
2015-08-03 |
2019-07-16 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017079759A1
(en)
|
2015-11-06 |
2017-05-11 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-c]pyridines and their anti-inflammatory uses thereof
|
|
WO2017192228A1
(en)
*
|
2016-05-06 |
2017-11-09 |
Albert Einstein College Of Medicine, Inc. |
Pak1 inhibitors and uses thereof
|
|
MY199242A
(en)
|
2016-06-01 |
2023-10-22 |
Samumed Llc |
Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
|
|
BR112019008061A2
(pt)
|
2016-10-21 |
2019-09-17 |
Samumed Llc |
métodos de uso de indazol-3-carboxamidas e seu uso como inibidores da via de sinalização de wnt/b-catenina
|
|
DE112017005364T5
(de)
|
2016-10-24 |
2019-07-18 |
Precision Combustion, Inc. |
Regenerativer festoxidstapel
|
|
MA46696A
(fr)
|
2016-11-07 |
2019-09-11 |
Samumed Llc |
Formulations injectables à dose unique prêtes à l'emploi
|
|
WO2018106643A1
(en)
|
2016-12-06 |
2018-06-14 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic azoles for the treatment of demyelinating diseases
|
|
WO2018106646A1
(en)
|
2016-12-06 |
2018-06-14 |
Vertex Pharmaceuticals Incorporated |
Aminotriazoles for the treatment of demyelinating diseases
|
|
WO2018106641A1
(en)
|
2016-12-06 |
2018-06-14 |
Vertex Pharmaceuticals Incorporated |
Pyrazoles for the treatment of demyelinating diseases
|
|
GB201710851D0
(en)
|
2017-07-06 |
2017-08-23 |
Galápagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
|
|
CN109384803B
(zh)
*
|
2017-08-09 |
2021-08-31 |
广州市恒诺康医药科技有限公司 |
Atx抑制剂及其制备方法和应用
|
|
US20200253959A1
(en)
|
2017-08-09 |
2020-08-13 |
Galapagos Nv |
Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
|
|
US20210106582A1
(en)
|
2017-11-15 |
2021-04-15 |
Galapagos Nv |
Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
|
|
AU2019220064A1
(en)
*
|
2018-02-14 |
2020-10-01 |
Suzhou Sinovent Pharmaceuticals Co., Ltd. |
Heterocyclic compound, application thereof and pharmaceutical composition comprising same
|
|
JP7274767B2
(ja)
*
|
2018-05-24 |
2023-05-17 |
▲広▼州市恒▲諾▼康医▲薬▼科技有限公司 |
芳香族複素環式化合物及びその医薬組成物
|
|
WO2019228403A1
(en)
|
2018-05-29 |
2019-12-05 |
Fronthera U.S. Pharmaceuticals Llc |
Autotaxin inhibitors and uses thereof
|
|
SG11202012524YA
(en)
|
2018-07-27 |
2021-01-28 |
Mitsubishi Tanabe Pharma Corp |
Novel 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same
|
|
GB201812861D0
(en)
|
2018-08-08 |
2018-09-19 |
Galapagos Nv |
Methods of administering therapy
|
|
PL3873472T3
(pl)
|
2018-10-29 |
2023-12-27 |
Boehringer Ingelheim International Gmbh |
Nowe pirydazyny
|
|
JP2022515256A
(ja)
|
2018-12-25 |
2022-02-17 |
ソル － ゲル テクノロジーズ リミテッド |
Ｅｇｆｒ阻害剤を含む組成物による皮膚障害の治療
|
|
GB201904375D0
(en)
*
|
2019-03-29 |
2019-05-15 |
Galapagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
|
CN113874354B
(zh)
*
|
2019-06-04 |
2024-02-20 |
江苏恒瑞医药股份有限公司 |
吡啶酮类衍生物、其制备方法及其在医药上的应用
|
|
US20220273752A1
(en)
*
|
2019-07-03 |
2022-09-01 |
Cornell University |
Modulation of dendritic cell function by the phospholipid messenger lpa
|
|
US11485727B2
(en)
|
2019-07-22 |
2022-11-01 |
Boehringer Ingelheim International Gmbh |
N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulators
|
|
US12391667B2
(en)
|
2019-07-22 |
2025-08-19 |
Boehringer Ingelheim International Gmbh |
N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as Autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseases
|
|
US11465982B2
(en)
*
|
2019-07-22 |
2022-10-11 |
Boehringer Ingelheim International Gmbh |
Pyridazines
|
|
EP3782997A1
(en)
|
2019-08-19 |
2021-02-24 |
Galapagos N.V. |
Fused pyrimidine compounds and pharmaceutical compositions thereof for the treatment of fibrotic diseases
|
|
CA3149062A1
(en)
*
|
2019-09-06 |
2021-03-11 |
Xuejun Zhang |
Pyrimidine compound and preparation method therefor
|
|
WO2021088957A1
(zh)
*
|
2019-11-07 |
2021-05-14 |
广州市恒诺康医药科技有限公司 |
芳杂环化合物、其药物组合物及其应用
|
|
CN111004235A
(zh)
*
|
2019-11-29 |
2020-04-14 |
沈阳药科大学 |
一种ATX抑制剂Ziritaxestat的合成方法
|
|
CN113493453B
(zh)
*
|
2020-04-07 |
2023-06-16 |
江苏恒瑞医药股份有限公司 |
稠合芳香环类衍生物、其制备方法及其在医药上的应用
|
|
JP2023533294A
(ja)
*
|
2020-07-09 |
2023-08-02 |
スージョウ アーク バイオファーマシューティカル カンパニー リミテッド |
Ａｔｘ阻害剤及びその製造方法並びに使用
|
|
CN114315825A
(zh)
*
|
2020-09-30 |
2022-04-12 |
江西济民可信集团有限公司 |
吡啶并咪唑衍生物及其制备方法和应用
|
|
WO2022074459A2
(en)
|
2020-10-06 |
2022-04-14 |
Ildong Pharmaceutical Co., Ltd. |
Autotaxin inhibitor compounds
|
|
EP4242208A4
(en)
*
|
2020-11-04 |
2025-01-15 |
Xizang Haisco Pharmaceutical Co., Ltd. |
DEUTERATED DERIVATIVE USED AS ATX INHIBITOR, AND ITS APPLICATION
|
|
US20240002401A1
(en)
*
|
2020-11-16 |
2024-01-04 |
Guangzhou Henovcom Bioscience Co., Ltd. |
Imidazothiazole compounds, pharmaceutical compositions, and uses thereof
|
|
FI4274572T3
(fi)
|
2021-01-05 |
2026-03-27 |
Zydus Lifesciences Ltd |
Uusia autotaksiinin inhibiittoreita
|
|
JP2024506858A
(ja)
|
2021-02-02 |
2024-02-15 |
リミナル・バイオサイエンシーズ・リミテッド |
Ｇｐｒ８４アンタゴニストおよびその使用
|
|
KR20230153387A
(ko)
|
2021-02-02 |
2023-11-06 |
리미널 바이오사이언시스 리미티드 |
Gpr84 길항제 및 이의 용도
|
|
CA3239101A1
(en)
*
|
2021-11-25 |
2023-06-01 |
Gang Deng |
Tricyclic derivative and preparation method therefor and application thereof
|
|
WO2023235871A2
(en)
*
|
2022-06-03 |
2023-12-07 |
Seer, Inc. |
Systems, compositions, and methods relating to neurodegenerative diseases
|
|
KR102587919B1
(ko)
*
|
2022-07-22 |
2023-10-11 |
주식회사 넥스트젠바이오사이언스 |
신규한 헤테로사이클릭 화합물 및 이를 포함하는 오토탁신 저해용 약학 조성물
|
|
EP4565568A1
(en)
|
2022-08-02 |
2025-06-11 |
Liminal Biosciences Limited |
Heteroaryl carboxamide and related gpr84 antagonists and uses thereof
|
|
EP4565569A1
(en)
|
2022-08-02 |
2025-06-11 |
Liminal Biosciences Limited |
Aryl-triazolyl and related gpr84 antagonists and uses thereof
|
|
WO2024028365A1
(en)
|
2022-08-02 |
2024-02-08 |
Liminal Biosciences Limited |
Substituted pyridone gpr84 antagonists and uses thereof
|
|
GR1010570B
(el)
|
2022-12-22 |
2023-11-17 |
Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Α.Β.Ε.Ε., |
4-(2-(4-((2,4-διοξοθειαζολιδιν-5-υλ)μεθυλ)φαινοξυ) παραγωγα με δραση αναστολης της αυτοταξινης
|